Vasoactive Intestinal Peptide (VIP) is a highly conserved neuropeptide with broad biological activity. Since its discovery in the early 1970s, VIP has been studied extensively for its pleiotropic functions across the nervous, immune, endocrine, and respiratory systems (Said & Mutt; Said). Its wide distribution and diverse receptor interactions make it a subject of interest in a growing number of experimental models. This blog offers a comprehensive review of VIP’s mechanisms, major domains of application, and emerging relevance in preclinical science, with a focus on its observed roles in research contexts.
VIP Peptide:
A Comprehensive Overview of Its Mechanisms and Research Applications
What is VIP Peptide?
VIP is a 28-amino-acid peptide originally isolated from the porcine small intestine (Said & Mutt). It belongs to the secretin/glucagon superfamily and is recognized as both a neurotransmitter and a regulatory peptide hormone in biological systems (Said). VIP is expressed in the central and peripheral nervous systems, as well as in immune tissues, endocrine organs, and the gastrointestinal tract.
In experimental models, VIP has been observed to influence vasodilation, neurotransmission, smooth muscle activity, immune regulation, and circadian rhythm signaling (Watanabe). These findings have made it a widely studied molecule in research on neurodegeneration, inflammatory processes, metabolic regulation, and pulmonary function.
Mechanism of Action
VIP has been observed in experimental systems to initiate receptor-ligand interactions that activate intracellular signaling pathways. These pathways operate through second messengers and transcriptional regulators, providing a framework for understanding downstream processes such as inflammatory signaling, neurotransmission, and vascular regulation across multiple cell types (Said).
VIP interacts with two class B G-protein-coupled receptors, VPAC1 and VPAC2, which are distributed across neurons, immune cells, smooth muscle, and epithelial tissues (Harmar et al.). Receptor activation stimulates adenylate cyclase and increases intracellular cyclic AMP (cAMP) levels.
Elevated cAMP subsequently activates protein kinase A (PKA) and CREB (cAMP response element-binding protein), initiating transcriptional programs. In experimental systems, these programs have been observed to modulate signaling pathways related to inflammatory mediators, neuronal plasticity, smooth muscle activity, and immune cell responses (Delgado et al.; Watanabe).
- Reported to stimulate nitric oxide (NO) production via endothelial nitric oxide synthase (eNOS), an effect documented in vascular signaling studies (Sawmiller & Henning)
- In some contexts, shown to activate phospholipase C (PLC) and mobilize intracellular calcium (Harmar et al.)
- Observed to interact with transcription factors such as NF-κB, leading to measurable changes in cytokine expression profiles in experimental systems (Delgado et al.)
Collectively, these findings characterize VIP as a peptide with diverse signaling interactions that have been documented across experimental models, including pathways related to inflammation, neurotransmission, and vascular regulation.
Key Research Applications
Neuroprotection and Cognitive Function
VIP has been widely employed in preclinical research to study mechanisms involved in neuronal survival, synaptic plasticity, and memory-related signaling processes (Watanabe). Experimental models have employed VIP to probe pathways related to glutamate-induced excitotoxicity, particularly through activation of VIP receptors and protein kinase A signaling (Shoge et al.; Brenneman et al.). The VIP/VPAC2 system has further been utilized to investigate glutamate transporter regulation in neuroprotection-focused studies (Nishimoto et al.).
More broadly, VIP is applied in neurodegenerative and brain injury research as a molecular tool for examining pathways associated with cognitive signaling, blood-brain barrier function, and oxidative stress responses in laboratory systems (Watanabe).
Psychiatric and Behavioral Research
VIPergic neurons have been investigated in research settings for their role in regulating social behavior, stress responses, and emotional signaling pathways. Studies suggest that VIP interacts with the hypothalamic-pituitary-adrenal (HPA) axis and influences the expression of neuropeptides such as oxytocin and vasopressin (Said).
In behavioral research models, VIP has been studied to examine mechanisms underlying anxiety-like and depression-like responses (Simon et al.). It has also been studied within the suprachiasmatic nucleus (SCN), the master circadian clock, where VIP serves as a tool for probing pathways of circadian rhythm synchronization and sleep-wake cycle regulation (Harmar et al.).
Immunomodulation
One of the most frequently studied areas of VIP research involves its role as an endogenous immunomodulator. In laboratory systems, VIP has been examined for its ability to influence cytokine signaling, including the downregulation of pro-inflammatory mediators such as TNF-α, IL-1β, and IL-6, alongside the upregulation of anti-inflammatory cytokines such as IL-10 (Delgado et al.).
Research models have also employed VIP to investigate immune polarization, particularly in its observed effects on Th1, Th2, and Th17 pathways. These applications position VIP as a subject of interest for examining mechanisms relevant to autoimmune and inflammatory processes in preclinical settings (Watanabe).
Pulmonary and Respiratory Research
VIP has been investigated in respiratory research for its activity as a bronchodilator and vasodilator within experimental systems. Observational studies have reported differences in VIP concentrations between asthma-affected groups and healthy controls, while histological analyses have examined alterations in VIP expression within pulmonary nerve fibers (Cardell et al.; Ollerenshaw et al.).
Beyond observational work, VIP and related analogs such as aviptadil have been applied in experimental models to explore mechanisms of oxygenation and pulmonary vascular regulation (Zhong et al.). These investigations underscore the peptide’s role in respiratory-focused research, particularly in studies of airway reactivity and vascular signaling.
Gastrointestinal Motility and Secretion
VIP has been studied for its regulatory role within the gastrointestinal system, particularly in relation to smooth muscle activity, intestinal water and electrolyte transport, and gastric acid modulation. These functions have been characterized primarily through experimental models investigating enteric nervous system signaling and epithelial homeostasis (Said).
Research in this area has explored VIP expression within the submucosal and myenteric plexuses, with altered levels being reported in association with motility dysfunction and mucosal inflammation under laboratory conditions (Wu et al.). Such investigations position VIP as a subject of ongoing interest for studying mechanisms underlying gastrointestinal regulation in preclinical research.
Cardiovascular Research Applications
VIP has been examined in vascular research for its strong vasodilatory activity, which in controlled studies has been measured as significantly greater than that of acetylcholine — a neurotransmitter frequently used as a reference compound for inducing vasodilation in experimental vascular systems (Henning & Sawmiller). In laboratory models, VIP has been used to investigate changes in coronary vascular resistance mediated through nitric oxide and cAMP-dependent pathways.
Additional research has used VIP in cardiovascular models to study its influence on pulmonary artery pressure and cardiac output parameters (Petkov et al.). These investigations position VIP as a focus of cardiovascular research aimed at examining vascular physiology and signaling regulation.
Tumor Biology and VPAC Expression
Research has shown that VPAC receptors, particularly VPAC1, can be overexpressed in a variety of tumor models. This has led to the use of VIP and its analogs in oncology research, where they are employed to study receptor distribution and signaling mechanisms (Watanabe).
Radiolabeled VIP analogs have been utilized in experimental settings to investigate selective binding and receptor-mediated localization in tumor research models (Reubi et al.; Virgolini et al.). Other studies have examined how VIP-related signaling may influence tumor microenvironment dynamics and immune interactions in laboratory systems (Petersen et al.).
Collectively, this work positions VIP as a subject of interest for experimental oncology, with emphasis on receptor expression patterns and tumor-associated signaling pathways.
Research Considerations
When designing studies that incorporate VIP, researchers should be aware of several factors that influence how the peptide is used and interpreted in experimental systems:
01
Short half-life and degradation
A well-documented limitation of VIP research is its rapid enzymatic breakdown in vivo. The native peptide has a short half-life, which constrains its utility in long-term model systems. Stabilized analogs such as RO25-1553 and delivery strategies like nanoparticle formulations have been developed for use in research settings to address this challenge (Watanabe; Dewit et al.).
02
Receptor specificity and distribution
VPAC1 and VPAC2 exhibit distinct expression patterns across tissues. Depending on the study objective, receptor-selective agonists or antagonists may be required to isolate pathway-specific effects (Harmar et al.).
03
Receptor variability across models
Differences in receptor affinity and downstream signaling have been reported between experimental systems, underscoring the need for model-specific interpretation of findings (Harmar et al.).
04
Regulatory classification
VIP peptides are not approved for clinical use and should be handled as investigational compounds intended strictly for laboratory research.
Future Research Directions
Ongoing investigations continue to examine VIP in preclinical models related to immune regulation, neurobiology, and behavioral research. Studies have focused on how VIP contributes to maintaining homeostatic balance in experimental systems and how it interacts with neuronal and immune pathways (Watanabe).
Research has also explored the VIP/VPAC axis in oncology, where it has been studied for its role in receptor-mediated signaling and tumor microenvironment models. In addition, VIP is frequently investigated in circadian biology research, where it provides a framework for examining sleep-wake regulation and related signaling processes.
Advances in peptide delivery approaches—including stabilized analogs, sustained-release systems, and receptor-targeted carriers—are being developed to enhance experimental design and extend the scope of VIP-based research (Zhong et al.).
Where to Get VIP Peptide for Research
For researchers studying VIP in the context of immune signaling, neurobiology, or vascular regulation, it is essential to source high-purity, research-grade material. Because of VIP’s sensitivity to degradation and its wide range of experimental applications, consistency in formulation, handling, and documentation is critical for reproducibility.
At Tydes, we provide:
- GMP-certified, third-party tested peptides to ensure purity and reproducibility
- Transparent Certificates of Analysis (COA) available for every lot
- Temperature-controlled shipping to preserve stability
- Responsive support and secure ordering for seamless access to research materials
For VIP peptide formulations backed by rigorous quality control, Tydes offers a reliable foundation for high-integrity peptide research.
VIP peptide represents one of the most extensively studied signaling molecules in peptide research. Its capacity to interact with immune, nervous, respiratory, and endocrine systems has made it a frequent subject of investigation across diverse experimental models.
As scientific interest expands, VIP continues to be used in studies of inflammation, tissue signaling, neurobehavioral regulation, and tumor biology. Its broad receptor distribution and well-characterized signaling pathways provide researchers with a framework for probing complex physiological networks under controlled laboratory conditions.
For investigators working in fields such as neuroimmunology, circadian biology, or vascular signaling, VIP remains an important subject of research inquiry, contributing to ongoing efforts to better understand peptide-regulated biological systems.
With rigorously tested peptide formulations available from Tydes, research can progress with the precision and reliability required for high-impact discovery.